Czech MPs concerned over EU pharma package marketing protection changes on 30/10/23 The debate over the EU pharmaceutical package is currently in full swing in the Czech Republic, with discussions among Czech lawmakers revealing that the proposed changes to data and marketing protection are raising remarkable concerns.
Extension of COVID-19 vaccine waiver back on the table on 27/10/23 The extension of the COVID-19 vaccine waiver to include diagnostics and treatments will once again be on the agenda at the World Trade Organisation (WTO) Council on Trade-related aspects of Intellectual Property Rights (TRIPS) on Monday and Tuesday (30-31 October).
EU needs to step up to unleash gene therapies potential, stakeholders say on 27/10/23 While gene therapies have the potential to transform the approach to rare diseases and improve the quality of life for patients, stakeholders and patients complain that they are very expensive to develop and difficult to access.
The complexity and rewards of gene treatments for rare diseases on 27/10/23 Gene therapies can transform the approach to rare diseases and improve the quality of life for patients. But developing and accessing them is hampered by regulatory burdens, cost and reimbursment schemes. In this special report, Euractiv takes a look at...
Violence against women: Compromise not in sight on 26/10/23 While the Spanish EU Council Presidency reaffirmed its commitment to address gender-based violence, the European Parliament’s rapporteurs are not so confident and do not expect an agreement this year.
EU Council reaches negotiating position on substances of human origin on 26/10/23 The Council of the EU approved on Wednesday (25 October) its position on the revision of safety and quality standards of substances of human origin (SoHO), which has been welcomed by patients' associations and parliamentarians.
Rethinking global health initiatives in Astana on 26/10/23 Speaking on the sidelines of a World Health Organisation conference in Astana, a European Commission official praised Kazakhstan's "impressive" efforts to improve its healthcare but recognised that similar long-term efforts can be challenging for many developing countries that struggle with funding.
New genomic techniques – What lies ahead? on 25/10/23 New genomic techniques (NGTs) and their products have been rapidly developing in the last 20 years in many parts of the world, with some applications already on the market of some EU trade partners. On 5 July 2023, the European...
Latest News
